V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009653 | 310004967 | 1.69 | 107 | Curative (C) | 2017-02-09 | 2017-04-03 | ALL UKALL2011 Del Int C Recon PAsp | N | N | 310019551 | BEXAROTENE |
| 310009654 | 310008154 | 1.6 | 63.85 | Curative (C) | 2015-11-24 | 2015-11-25 | Bexarotene | 02 | N | 310019558 | BEXAROTENE |
| 310009656 | 310004974 | 1.78 | null | null | 2018-03-24 | 2018-04-02 | ETOPOSIDE | N | N | 310019563 | ETOPOSIDE |
| 310009657 | 310004976 | 1.81 | 69.1 | Palliative (P) | 2016-06-09 | 2017-07-26 | Rituximab (Maintenance) | 02 | N | 310019567 | RITUXIMAB |
| 310009659 | 310004980 | null | 50.8 | Disease modification (D) | null | 2018-03-22 | Cisplatin | N | N | 310019580 | CISPLATIN |
| 310009660 | 310004981 | null | 77.9 | Curative (C) | 2014-05-24 | 2014-05-26 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310019583 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009661 | 310008163 | 1.58 | null | null | 2016-06-28 | 2017-09-14 | Rituximab | 02 | N | 310019585 | RITUXIMAB |
| 310009662 | 310011834 | 1.86 | 71.4 | Palliative (P) | 2014-05-06 | 2014-05-29 | RITUXIMAB + prednisolone + VINBLASTINE + prednisolone | N | N | 310019596 | PEG INTERFERON |
| 310009663 | 310004983 | 1.76 | 68 | Neo-adjuvant (N) | 2015-06-04 | 2015-08-20 | VIDE | 02 | N | 310019610 | OXALIPLATIN + MDG |
| 310009664 | 310004985 | 1.85 | 8.9 | Neo-adjuvant (N) | null | 2015-12-08 | PEG INTERFERON | 02 | N | 310019619 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 310009665 | 310004988 | 1.48 | 69.7 | Palliative (P) | null | 2013-09-03 | Imatinib 400mg | 02 | N | 310019631 | CETUXIMAB |
| 310009666 | 310004989 | 1.64 | 85.6 | Palliative (P) | 2018-09-06 | 2018-11-01 | Capecitabine | N | N | 310019634 | OXALIPLATIN + MDG |
| 310009667 | 310004989 | 1.73 | 63 | null | 2015-12-01 | 2016-09-29 | Eribulin | 02 | N | 310019634 | PEMETREXED |
| 310009668 | 310011735 | 1.67 | 68 | Palliative (P) | 2014-05-01 | 2014-05-02 | METHOTREXATE | Y | N | 310019645 | CETUXIMAB |
| 310009669 | 310004990 | 1.76 | 68 | Palliative (P) | 2015-09-29 | 2015-09-29 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | N | N | 310019657 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 310009670 | 310009844 | null | 72 | null | 2018-06-05 | 2018-06-09 | DABRAFENIB + TRAMETINIB | N | N | 310019663 | BENDAMUSTINE |
| 310009671 | 310004993 | 1.73 | null | Curative (C) | 2016-01-09 | 2016-10-04 | Trabectedin | null | null | 310019672 | DHAP - R |
| 310009672 | 310004994 | 1.78 | 88.1 | Palliative (P) | 2015-03-20 | 2015-03-28 | DABRAFENIB | N | N | 310019674 | CAV |
| 310009673 | 310011280 | 1.82 | 65.5 | Adjuvant (A) | 2014-02-06 | 2014-02-07 | RUXOLITINIB | 2 | N | 310019677 | CAV |
| 310009674 | 310005002 | 1.77 | 58.8 | Palliative (P) | 2014-11-06 | 2014-11-06 | CARMUSTINE + THIOTEPA | 2 | N | 310019686 | PMITCEBO |
| 310009676 | 310005011 | 1.68 | null | Palliative (P) | 2016-04-06 | 2016-04-28 | Oxaliplatin + Modified de Gramont | 02 | N | 310019697 | TRASTUZUMAB |
| 310009677 | 310005014 | 1.77 | 81.2 | null | 2014-06-30 | 2014-08-05 | ICE + GCSF | 02 | N | 310019710 | ICE |
| 310009678 | 310005015 | 1.74 | 66.8 | Palliative (P) | 2016-09-15 | 2016-09-16 | DABRAFENIB | 2 | N | 310019714 | CARBO + GEMCITABINE + RITUXIMAB |
| 310009679 | 310005017 | 1.6 | 24.3 | Palliative (P) | 2014-11-07 | 2014-11-16 | CAV | null | null | 310019722 | TEMOZOLOMIDE |
| 310009680 | 310008181 | 1.7 | 82.4 | Palliative (P) | 2017-02-27 | 2017-03-06 | CAV | N | N | 310019735 | CYTARABINE + METHOTREXATE |
| 310009681 | 310005021 | 1.7 | 92.2 | null | 2017-03-01 | 2017-03-26 | Chlorambucil | 02 | N | 310019738 | LENALIDOMIDE |
| 310009682 | 310005023 | 1.72 | 67.9 | null | 2011-02-06 | 2014-09-29 | Azacitidine | 2 | N | 310019750 | IFOSFAMIDE |
| 310009683 | 310008187 | null | 62.9 | Neo-adjuvant (N) | 2013-06-15 | 2013-07-10 | R GCVP | N | N | 310019761 | TOPOTECAN |
| 310009684 | 310005028 | null | null | Palliative (P) | 2017-12-24 | 2018-01-26 | Bortezomib + Cyclophos + Dex | 02 | null | 310019769 | TRABECTEDIN |
| 310009685 | 310005029 | 0 | 91.1 | Palliative (P) | 2018-03-11 | 2018-03-11 | BCG Intravesical | 02 | null | 310019770 | CVP |
| 310009687 | 310009856 | null | null | Disease modification (D) | 2015-11-26 | 2015-11-26 | Ifosfamide | N | null | 310019790 | GEMCITABINE + OXALIPLATIN |
| 310009689 | 310008192 | 1.78 | 87.2 | Curative (C) | 2017-12-29 | 2017-12-29 | Oxaliplatin + Modified de Gramont | 02 | N | 310019802 | DHAP |
| 310009690 | 310005036 | 1.72 | 28.2 | Disease modification (D) | 2016-03-13 | 2016-08-13 | Gemcitabine + Oxaliplatin | N | N | 310019814 | CYCLO + DOXORUBICIN + VINCRISTINE |
| 310009691 | 310009858 | 1.84 | 70 | Palliative (P) | 2017-01-23 | 2017-03-27 | Cytarabine Low Dose | 02 | null | 310019816 | IVA |
| 310009692 | 310005038 | 0 | 79.3 | Palliative (P) | 2016-09-06 | 2016-09-20 | EP | N | null | 310019827 | IMATINIB |
| 310009693 | 310005039 | 1.8 | 69.6 | Palliative (P) | 2018-07-09 | 2018-07-09 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 310019827 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 310009694 | 310005040 | 1.8 | null | Palliative (P) | 2013-06-26 | 2014-03-31 | TEMOZOLOMIDE | N | N | 310019833 | OXALIPLATIN + MDG |
| 310009695 | 310008197 | 1.68 | null | Disease modification (D) | 2014-09-05 | 2014-09-05 | Cytarabine High Dose | N | null | 310019841 | RCEOP |
| 310009696 | 310005043 | 1.54 | null | Curative (C) | 2017-04-17 | 2017-04-23 | FEC 60 or 75 | N | N | 310019843 | ICON TRIAL |
| 310009697 | 310008199 | 1.78 | 62.65 | Palliative (P) | 2015-12-03 | 2015-12-04 | LENALIDOMIDE | N | N | 310019846 | METHOTREXATE HIGH DOSE |
| 310009698 | 310009861 | 1.55 | 80 | Curative (C) | null | 2014-05-23 | IPILIMUMAB + NIVOLUMAB | 02 | N | 310019847 | PEMETREXED |
| 310009699 | 310005045 | 1.84 | null | Not known (9) | 2016-12-29 | 2016-12-29 | GC Int Guide Excranial GermCell JEB | N | null | 310019851 | EVEROLIMUS |
| 310009700 | 310005048 | 1.72 | 101.1 | Curative (C) | 2013-11-09 | 2013-11-26 | Dacarbazine | null | N | 310019858 | CEV |
| 310009701 | 310008202 | 1.87 | 79.3 | Palliative (P) | null | 2017-11-09 | Capecitabine (21 day) + Irinotecan | N | N | 310019865 | BENDAMUSTINE |
| 310009702 | 310005051 | 1.68 | 59.2 | null | 2017-06-07 | 2018-04-26 | Fludarabine + Melphalan RIC Allo | N | N | 310019868 | RUXOLITINIB |
| 310009703 | 310008203 | 1.73 | 82 | Palliative (P) | 2018-01-08 | 2018-01-12 | CISPLATIN + FLUOROURACIL | N | N | 310019870 | CVP R |
| 310009704 | 310008203 | 1.58 | 62.5 | Palliative (P) | 2015-01-28 | 2017-10-01 | Olaparib | N | N | 310019870 | DABRAFENIB + TRAMETINIB |
| 310009705 | 310011894 | 1.7 | 118 | Curative (C) | null | 2016-12-01 | Topotecan (oral) | 2 | N | 310019894 | IVE + METHOTREXATE |
| 310009706 | 310005055 | 1.7 | 61.8 | Curative (C) | 2017-06-18 | 2017-06-20 | Trabectedin | N | N | 310019897 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310009707 | 310005057 | 1.82 | 0 | Palliative (P) | 2017-04-07 | 2017-04-10 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | N | 310019900 | DOXORUBICIN + OLARATUMAB |